| Ranibizumab 0.3 mg for persistent diabetic macular edema after recent, frequent, and chronic bevacizumab: the ROTATE trial C Fechter, H Frazier, WB Marcus, A Farooq, H Singh, DM Marcus Ophthalmic Surgery, Lasers and Imaging Retina 47 (11), 1-18, 2016 | 24 | 2016 |
| Endolaserless vitrectomy with intravitreal aflibercept injection for proliferative diabetic retinopathy-related vitreous hemorrhage (LASER LESS TRIAL) DM Marcus, H Singh, DC Starnes, H Walia, A Farooq, H Frazier, ... Journal of VitreoRetinal Diseases 2 (3), 127-137, 2018 | 4 | 2018 |
| Intravitreal aflibercept for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian population: rival results A Farooq, H Frazier, WB Marcus, C Fechter, H Singh, DM Marcus Ophthalmic Surgery, Lasers and Imaging Retina 48 (1), 34-52, 2017 | 4 | 2017 |
| Complications, compliance and 2 year outcomes after endolaserless vitrectomy with aflibercept monotherapy for pdr-related vitreous hemorrhage R Levy, DC Starnes, H Walia, A Farooq, H Frazier, W Marcus, E Samy, ... Investigative Ophthalmology & Visual Science 61 (7), 1380-1380, 2020 | 1 | 2020 |
| Endolaserless vitrectomy with intravitreal aflibercept injection (IAI) for proliferative diabetic retinopathy (PDR)-related vitreous hemorrhage: LASER LESS TRIAL 1-year results DC Starnes, R Lalane, H Walia, A Farooq, H Frazier, W Marcus, H Singh, ... Investigative Ophthalmology & Visual Science 60 (9), 6559-6559, 2019 | 1 | 2019 |
| Kostenvergleich zugelassener intravitrealer Therapien bei nicht ausreichend auf primäre Therapie ansprechendem diabetischem Makulaödem mit fovealer Beteiligung in Deutschland AS Neubauer, C Haritoglou, MW Ulbig Klinische Monatsblätter für Augenheilkunde 236 (02), 180-191, 2019 | 1 | 2019 |
| Acute Macular Neuroretinopathy Following Moderna mRNA COVID-19 Vaccination WB Marcus, RA Goldberg Retinal Cases and Brief Reports, 10.1097, 2022 | | 2022 |
| Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: ROTATED Trial 52 Week Results C Taylor, H Frazier, P Rex, W Marcus, D Starnes, H Walia, H Singh, ... Investigative Ophthalmology & Visual Science 60 (9), 3642-3642, 2019 | | 2019 |
| Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: 6-Month ROTATED Trial Results DM Marcus, H Frazier, P Rex, W Marcus, D Starnes, H Walia, H Singh, ... Investigative Ophthalmology & Visual Science 59 (9), 3598-3598, 2018 | | 2018 |
| Ranibizumab (0.3 MG) For Persistent Diabetic Macular Edema (DME) After Recent, Frequent, And Chronic Bevacizumab: 1-Year Rotate Trial Results A Farooq, H Frazier, C Fechter, WB Marcus, H Singh, DM Marcus Investigative Ophthalmology & Visual Science 57 (12), 2093-2093, 2016 | | 2016 |
| Intravitreal Aflibercept For Neovascular Polypoidal Choroidal Vasculopathy In A Predominantly Non-Asian Population: 1-Year Rival Trial Results DM Marcus, A Farooq, H Frazier, C Fechter, WB Marcus, H Singh Investigative Ophthalmology & Visual Science 57 (12), 535-535, 2016 | | 2016 |
